NasdaqCM:EXASBiotechs
Assessing Exact Sciences (EXAS) Valuation After A Strong Year Of Shareholder Returns
Why Exact Sciences (EXAS) is on investors’ radar
Exact Sciences (EXAS) has drawn attention after a period of strong 1 year total return of 108.16% and past 3 months return of 19.88%, prompting closer scrutiny of its current valuation.
See our latest analysis for Exact Sciences.
At a share price of US$103.31, Exact Sciences has seen a strong 1 year total shareholder return of 108.16%, while its 90 day share price return of 19.88% suggests momentum has recently picked up after a more muted...